BNTCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Benitec Biopharma Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 14, 2026
$8.36+0.25 (+3.08%)
Close on Oct 19, 2026
- Market cap
- $413.29M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
99.4%
35M of 35M shares
Institutional holders
87
12 new, 10 sold out
Net institutional buying
5M
In Q2 2026
Insider trades, 12 months
14 buys · 0 sales
Net bought $22.44M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Steven M. Oliveira | 791,235 | 8.89% | 13G (passive) | Apr 22, 2024 |
| Franklin Advisers, Inc. | 4,493,691 | 18.10% | 13G (passive) amendment | Dec 31, 2024 |
| Franklin Resources, Inc. | 3,751,709 | 10.60% | 13G (passive) amendment | Dec 31, 2025 |
| Janus Henderson Group PLC | 3,382,836 | 9.99% | 13G (passive) amendment | Nov 28, 2025 |
| Adage Capital Management, L.P. | 264,510 | 9.99% | 13G (passive) amendment | Dec 31, 2023 |
| RA Capital Healthcare Fund, L.P. | 1,850,000 | 5.50% | 13G (passive) | Nov 7, 2025 |
| Suvretta Capital Management, LLC | 17,761,945 | 44.10% | 13D (active) amendment | Nov 7, 2025 |
| Aaron Cowen | 15,623,659 | 49.90% | 13D (active) amendment | Mar 26, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BNTC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 11,548,351 | 33.11% | $154.52M | – | 2.83% |
| Nantahala Capital Management, LLC | 2,976,742 | 8.53% | $39.83M | +1,538,371 | 0.66% |
| Jupiter Topco LLC | 2,478,547 | 7.11% | $33.11M | New | 0.01% |
| Franklin Resources Inc | 2,412,888 | 6.92% | $32.28M | +34,729 | 0.01% |
| Adage Capital Partners Gp, L.L.C. | 2,120,672 | 6.08% | $28.37M | – | 0.04% |
| Ra Capital Management, L.P. | 1,850,000 | 5.30% | $24.75M | – | 0.22% |
| BlackRock, Inc. | 1,407,138 | 4.03% | $18.83M | +221,397 | 0.00% |
| Simplify Asset Management Inc. | 1,005,557 | 2.88% | $13.45M | +443,315 | 0.19% |
| Vanguard Capital Management LLC | 954,533 | 2.74% | $12.77M | +22,977 | 0.00% |
| Infinitum Asset Management, LLC | 923,006 | 2.65% | $12.35M | – | 1.26% |
| Millennium Management LLC | 921,299 | 2.64% | $12.33M | +269,235 | 0.00% |
| Alyeska Investment Group, L.P. | 750,000 | 2.15% | $10.04M | – | 0.03% |
| Silverarc Capital Management, LLC | 679,826 | 1.95% | $9.10M | −37,899 | 0.95% |
| Balyasny Asset Management L.P. | 650,503 | 1.86% | $8.70M | −3,332 | 0.01% |
| Geode Capital Management, LLC | 611,736 | 1.75% | $8.19M | +87,632 | 0.00% |
| Ameriprise Financial Inc | 401,245 | 1.15% | $5.37M | −7,525 | 0.00% |
| State Street Corp | 377,973 | 1.08% | $5.06M | +39,724 | 0.00% |
| MYDA Advisors LLC | 250,000 | 0.72% | $3.35M | +25,000 | 0.50% |
| Schonfeld Strategic Advisors LLC | 235,357 | 0.67% | $3.15M | +82,178 | 0.01% |
| AWM Investment Company, Inc. | 187,977 | 0.54% | $2.52M | – | 0.22% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 87 | 35M | 99.4% | 12 / 36 | 22 / 10 | 6M | 0M |
| Q1 2026 | 88 | 32M | 93.1% | 25 / 35 | 13 / 8 | 3M | 1M |
| Q4 2025 | 72 | 32M | 90.8% | 20 / 27 | 15 / 4 | 9M | 1M |
| Q3 2025 | 56 | 23M | 66.4% | 6 / 28 | 9 / 7 | 1M | 0M |
| Q2 2025 | 57 | 23M | 65.0% | 25 / 13 | 12 / 5 | 2M | 1M |
| Q1 2025 | 37 | 22M | 62.8% | 10 / 2 | 25 / 3 | 1M | 64M |
| Q4 2024 | 30 | 85M | 100.0% | 8 / 15 | 4 / 3 | 27M | 3M |
| Q3 2024 | 25 | 62M | 100.0% | 8 / 5 | 8 / 0 | 36M | 0M |
| Q2 2024 | 18 | 26M | 73.9% | 6 / 8 | 2 / 1 | 20M | 0M |
| Q1 2024 | 13 | 6M | 16.7% | 0 / 4 | 2 / 0 | 0M | 0M |
| Q4 2023 | 13 | 5M | 15.5% | 3 / 3 | 1 / 1 | 0M | 0M |
| Q3 2023 | 11 | 6M | 16.4% | 11 / 0 | 0 / 0 | 6M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of BNTC | Value | % of fund | As of |
|---|---|---|---|---|---|
| Simplify Health Care ETF | 1,005,557 | 2.88% | $13.45M | 3.75% | Jun 30, 2026 |
| Franklin Biotechnology Discovery Fund | 995,152 | 2.85% | $11.65M | 1.01% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 649,542 | 1.86% | $8.69M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 533,504 | 1.53% | $7.14M | 0.01% | Jun 30, 2026 |
| Franklin Small Cap Growth Fund | 357,531 | 1.02% | $4.19M | 0.17% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 281,899 | 0.81% | $3.77M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 233,034 | 0.67% | $2.73M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 188,332 | 0.54% | $2.52M | 0.02% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 130,966 | 0.38% | $1.51M | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 99,969 | 0.29% | $1.16M | 0.01% | May 31, 2026 |
| iShares Micro-Cap ETF | 71,527 | 0.21% | $957.03K | 0.06% | Jun 30, 2026 |
| Schwab Small-Cap Index Fund | 51,745 | 0.15% | $605.93K | 0.01% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 42,298 | 0.12% | $488.96K | 0.00% | May 31, 2026 |
| Master Small Cap Index Series | 41,853 | 0.12% | $559.99K | 0.01% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 38,625 | 0.11% | $446.51K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Megan Boston | Chief Financial Officer, Director | 25,927 | 0.07% | Nov 20, 2025 |
| Jerel A. Banks | Chief Executive Officer, Director | – | – | Nov 20, 2025 |
| Sophie Mukadam | Chief Operating Officer | 6,016 | 0.02% | Nov 20, 2025 |
| J. Kevin Buchi | Director | 155,723 | 0.45% | Jun 30, 2026 |
| David Matthew Friedman | Director | – | – | May 28, 2026 |
| Sharon Mates | Director | – | – | Jan 26, 2026 |
| Aaron Cowen | Director, 10% owner | 1,848,156 | 5.30% | Dec 29, 2025 |
| Suvretta Capital Management, Llc | Director, 10% owner | 9,538,175 | 27.34% | Dec 29, 2025 |
| Averill Master Fund, Ltd. | Director, 10% owner | 7,920,175 | 22.71% | Dec 29, 2025 |
| Kishan Mehta | Director | – | – | Dec 3, 2025 |
| Edward F. Smith | Director | 0 | – | Dec 3, 2025 |
| Peter Francis | Director | 5,038 | 0.01% | Dec 3, 2025 |
| Averill Madison Master Fund, Ltd. | 10% owner | 1,826,653 | 5.24% | Dec 29, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| J. Kevin Buchi Director | Jun 29, 2026 | Gift | −51,813 | – | – | 52,097 |
| Aaron Cowen Director, 10% owner | Dec 29, 2025 | Buy | +11,587 | $13.44 | $155.73K | 1,848,156 |
| Aaron Cowen Director, 10% owner | Dec 29, 2025 | Buy | +65,800 | $13.44 | $884.35K | 9,700,195 |
| Aaron Cowen Director, 10% owner | Dec 26, 2025 | Buy | +2,516 | $13.10 | $32.96K | 1,836,569 |
| Aaron Cowen Director, 10% owner | Dec 26, 2025 | Buy | +14,320 | $13.10 | $187.59K | 9,634,395 |
| Aaron Cowen Director, 10% owner | Dec 23, 2025 | Buy | +42,600 | $12.85 | $547.41K | 9,620,075 |
| Aaron Cowen Director, 10% owner | Dec 23, 2025 | Buy | +7,400 | $12.85 | $95.09K | 1,834,053 |
| Averill Madison Master Fund, Ltd. 10% owner | Dec 22, 2025 | Buy | +2,892 | $12.08 | $34.94K | 1,826,653 |
| Averill Madison Master Fund, Ltd. 10% owner | Dec 22, 2025 | Buy | +16,650 | $12.08 | $201.13K | 9,577,475 |
| Averill Madison Master Fund, Ltd. 10% owner | Dec 19, 2025 | Buy | +13,950 | $11.48 | $160.15K | 9,560,825 |
| Averill Madison Master Fund, Ltd. 10% owner | Dec 19, 2025 | Buy | +2,434 | $11.48 | $27.94K | 1,823,761 |
| Averill Madison Master Fund, Ltd. 10% owner | Dec 18, 2025 | Buy | +1,515 | $11.24 | $17.03K | 1,821,327 |
| Averill Madison Master Fund, Ltd. 10% owner | Dec 18, 2025 | Buy | +8,700 | $11.24 | $97.79K | 9,546,875 |
| Suvretta Capital Management, Llc Director, 10% owner | Nov 7, 2025 | Buy | +730,370 | $13.50 | $9.86M | 9,538,175 |
| Suvretta Capital Management, Llc Director, 10% owner | Nov 7, 2025 | Buy | +751,111 | $13.50 | $10.14M | 1,819,812 |
| Suvretta Capital Management, Llc Director, 10% owner | Mar 31, 2025 | Buy | +1,267 | $12.63 | $16.00K | 1,068,031 |
| Suvretta Capital Management, Llc Director, 10% owner | Mar 31, 2025 | Buy | +9,503 | $12.63 | $120.02K | 8,802,748 |
| Suvretta Capital Management, Llc Director, 10% owner | Mar 31, 2025 | Buy | +670 | $13.22 | $8.86K | 1,068,701 |
| Suvretta Capital Management, Llc Director, 10% owner | Mar 31, 2025 | Buy | +5,057 | $13.22 | $66.85K | 8,807,805 |
| Aaron Cowen 10% owner | Mar 26, 2025 | Buy | +106,200 | $13.00 | $1.38M | 1,066,764 |
| Aaron Cowen 10% owner | Mar 26, 2025 | Buy | +793,800 | $13.00 | $10.32M | 8,793,245 |
| J. Kevin Buchi Director | Mar 12, 2025 | Gift | +103,626 | – | – | 103,626 |
| J. Kevin Buchi Director | Mar 12, 2025 | Gift | −103,626 | – | – | 284 |
| J. Kevin Buchi Director | Feb 27, 2025 | Option exercise | +51,813 | $3.86 | $200.00K | 103,910 |
| Aaron Cowen 10% owner | Dec 24, 2024 | Buy | +17,730 | $11.25 | $199.46K | 7,999,455 |
| Aaron Cowen 10% owner | Dec 24, 2024 | Buy | +2,288 | $11.25 | $25.74K | 960,554 |
| Aaron Cowen 10% owner | Dec 23, 2024 | Buy | +3,142 | $10.98 | $34.50K | 958,266 |
| Aaron Cowen 10% owner | Dec 23, 2024 | Buy | +24,360 | $10.98 | $267.47K | 7,981,725 |
| Suvretta Capital Management, Llc Director, 10% owner | Dec 3, 2024 | Buy | +37,190 | $9.60 | $357.02K | 7,957,365 |
| Suvretta Capital Management, Llc Director, 10% owner | Dec 3, 2024 | Buy | +4,810 | $9.60 | $46.18K | 955,124 |
| Averill Master Fund, Ltd. Director, 10% owner | Nov 20, 2024 | Buy | +24,360 | $10.22 | $248.96K | 7,920,175 |
| Averill Master Fund, Ltd. Director, 10% owner | Nov 20, 2024 | Buy | +3,076 | $10.22 | $31.44K | 950,314 |
| Averill Master Fund, Ltd. Director, 10% owner | Nov 19, 2024 | Buy | +12,430 | $9.73 | $120.94K | 7,895,815 |
| Averill Master Fund, Ltd. Director, 10% owner | Nov 19, 2024 | Buy | +1,570 | $9.73 | $15.28K | 947,238 |
| Averill Master Fund, Ltd. Director, 10% owner | Sep 26, 2024 | Option exercise | +4,605,000 | $3.86 | $17.78M | 6,663,415 |
| Averill Master Fund, Ltd. Director, 10% owner | Sep 26, 2024 | Option exercise | +588,236 | $1.93 | $1.14M | 2,058,415 |
| Averill Master Fund, Ltd. Director, 10% owner | Sep 26, 2024 | Option exercise | +148,210 | – | – | 945,668 |
| Averill Master Fund, Ltd. Director, 10% owner | Sep 26, 2024 | Option exercise | +576,347 | $3.86 | $2.22M | 797,458 |
| Averill Master Fund, Ltd. Director, 10% owner | Sep 26, 2024 | Option exercise | +1,219,970 | – | – | 7,883,385 |
| J. Kevin Buchi Director | Aug 11, 2023 | Buy | +51,813 | – | – | 52,097 |
| Megan Boston Executive Director | Aug 11, 2023 | Buy | +25,907 | – | – | 25,907 |
| Steven Michael Oliveira 10% owner | Dec 9, 2021 | Buy | +10,553 | $3.04 | $32.08K | 1,000,000 |
| Steven Michael Oliveira 10% owner | Nov 29, 2021 | Buy | +37,947 | $3.18 | $120.67K | 989,447 |
| Steven Michael Oliveira 10% owner | May 3, 2021 | Buy | +40,500 | $4.25 | $172.13K | 951,500 |
| Steven Michael Oliveira 10% owner | Apr 30, 2021 | Buy | +120,000 | $4.18 | $501.60K | 911,000 |
| Steven Michael Oliveira 10% owner | Apr 29, 2021 | Buy | +22,877 | $5.49 | $125.59K | 791,000 |
| Steven Michael Oliveira 10% owner | Apr 28, 2021 | Buy | +100,000 | $5.45 | $545.00K | 768,123 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.